NICHOLE PRESTWOOD: Open Payments
NPI 1225522709 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,181 in 119 payments from 15 companies in 2025. Trend: 2023 $1,865 · 2024 $2,376 · 2025 $2,181
Food & beverage: $2,015Education: $166
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $447 |
| Regeneron Healthcare Solutions, Inc. | 15 | $399 |
| ABBVIE INC. | 19 | $380 |
| GENZYME CORPORATION | 11 | $227 |
| UCB, Inc. | 24 | $217 |
| Novartis Pharmaceuticals Corporation | 6 | $133 |
| Organogenesis Inc. | 4 | $84 |
| PFIZER INC. | 5 | $78 |
| Incyte Corporation | 3 | $50 |
| LEO Pharma Inc. | 2 | $37 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, CIBINQO, OPZELURA, Rhapsido, LIBTAYO.
Industry payments across AL — which companies pay providers there.
